Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New antiasthma compound reported at Japanese congress

Dec. 1, 1997

European approvals for RPR's Nasacort AQ

Nov. 28, 1997

Bronchodilating mechanism of PDE IV inhibitors investigated using CP-80633

Nov. 27, 1997

Ono's elastase inhibitor poised to enter phase I in Europe

Nov. 27, 1997

Fujirebio, Nippon Chemiphar to codevelop antiasthma drug

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Dual CysLT1/H1 receptor antagonists described in patent literature

Nov. 25, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Accolate now available in Canada

Nov. 21, 1997

RPR redirects development of PDE IV inhibitor

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...